Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

RAN Biotechnologies Announces Distributorship Agreement with Fluigent

Published: Wednesday, July 16, 2014
Last Updated: Tuesday, July 15, 2014
Bookmark and Share
Agreement with Fluigent in France provides industry-leading solution for droplet microfluidic applications throughout EU region.

RAN Biotechnologies has entered into a distributorship  agreement with Fluigent  for distribution of RAN Biotechnologies products in Europe. 

“We are very excited to be distributing the products of RAN Biotechnologies,” said Dr. Jérémie Weber, CTO and co-founder of Fluigent. “Their chemicals and solutions are the state-of-the-art for droplet microfluidics. We believe the combination of RAN Biotechnologies reagents and our microfluidic instruments will lead to a very powerful platform for droplet microfluidic applications.”

Droplet microfluidics is an alternative technology for Lab-on-a-chip systems, where manipulation of discrete micro-droplets is performed. Such a technology is compatible with many chemicals and biologicals and allows the programmation of various digital fluidic operations. These valuable advantages have the potential to enhance biomedical research and secure a rapidly growing market share in diagnostics and therapeutics. 

“Our expertise in synthetic and surface chemistry in general and in surfactants in particular, allows us to develop advanced materials for microfluidics”, said Dr. Roger Nassar, founder and President of RAN Biotechnologies. Dr. Nassar added, “Partnering with Fluigent is a major step in our exposure efforts in Europe after winning the Young Entrepreneurs initiative (YEi’13) award, which is organized by the French Embassy in the United States and the French Innovation Network (Retis). It will help us to reach a wider microfluidic market and allow us to be part of important new technologies by advancing lab-on-a-chip applications.”

RAN Biotechnologies’ fluorosurfactants and microfluidic surface coatings stabilize water-in-oil emulsions for droplet microfluidics and can encapsulate biologicals, such as DNA, RNA, cells and proteins, permitting their study and interrogation. High-throughput single cell screening, DNA amplification and chemical reactions are some of the manipulations performed inside these unique droplets. 


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Fluigent and Micronit Microfluidics Collaborate
Companies have entered into a co-promotion agreement, enabling them to promote each other’s products.
Wednesday, October 24, 2012
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Blood Pressure Drug May Boost Effectiveness of Lung Cancer Treatment
Researchers at Imperial College London have suggested that the blood pressure drug may make a type of lung cancer treatment more effective.
Gene Regulation in Brain May Explain Repetitive Behaviors in Rett Syndrome Patients
The research could be a key step in developing treatments to eliminate symptoms that drastically impair the quality of life in Rett patients.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Iron Nanoparticles Make Immune Cells Attack Cancer
Researchers accidentally discover that nanoparticles invented for anemia treatment can trigger the immune system’s ability to destroy tumor cells.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
Uncovering Cancer’s ‘Invisibility Cloak’
Researchers discover cancer cell mechanism to become invisible to the body's immune system.
Genetic Impact of Endurance Training
Research has found that endurance training changes genetic activity in thousands of genes, giving rise to large number of altered RNA variants.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!